Bruker Introduces Novel Point-of-Need Applied Mass Spectrometry Tools for Accelerated Measurements without Chromatography
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
- Recent acquisition of DART™ (Direct Analysis Real-time Technology) innovator IonSense extends Bruker’s unique Point-of-Need (PoN) mass spectrometers
- Launch of DART-EVOQ® triple quadrupole mass spectrometer offers simple, robust, yet sensitive and specific PoN workflows for applied markets
-
New Bruker strategic partnership with
TOFWERK AG brings together skills and vision for next-generation high-speed, ultra-sensitive analytical solutions

DART-EVOQ PoN Mass Spec (Photo: Business Wire)
In
With DART in its portfolio, Bruker announces first applications with the launch of the DART-EVOQ system that extends applicability and performance for fast PoN mass spec measurements. DART-EVOQ users can rapidly identify samples, including many that do not ionize well using other methods. Innovative applications for combined DART-triple quad mass spectrometry include trace level volatile quantitation in grape harvests.
Dr.
In
Dr.
Bruker has a strong heritage in mass spectrometry in life sciences and applied markets such as food, environmental, forensics, industrial and clinical, e.g., with the MALDI Biotyper™ as the leading clinical mass spectrometry platform, with over 5000 systems in use in microbiology worldwide.
“Our expertise in developing novel workflows to overcome challenges faced by our customers is second to none,” commented
About
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. Please visit www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005371/en/
Media
T: +49 (421) 2205-2843
E: petra.scheffer@bruker.com
Investor Relations
Sr. Director Investor Relations &
T: +1 (978) 663–3660, ext. 1479
E: Investor.Relations@bruker.com
Source: